DrugPatentWatch Database Preview
Profile for Portugal Patent: 1506211
US Patent Family Members and Approved Drugs for Portugal Patent: 1506211
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Sign Up | Oct 4, 2020 | Astrazeneca Ab | BYDUREON | exenatide synthetic |
➤ Sign Up | Oct 4, 2020 | Astrazeneca Ab | BYDUREON PEN | exenatide synthetic |
➤ Sign Up | Oct 4, 2020 | Astrazeneca Ab | XIGDUO XR | dapagliflozin; metformin hydrochloride |
➤ Sign Up | Oct 4, 2020 | Astrazeneca Ab | FARXIGA | dapagliflozin |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |